About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

About time: why central nervous system prophylaxis timing in diffuse large B-cell lymphoma matters and does the protocol need updating?

Published:2022-10-27 Issue:11 Volume:15 Page:959-962
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Lewis Katharine Louise¹²³,Cheah Chan Yoon¹²⁴^ORCID

Affiliation:

1. Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia

2. University of Western Australia, Nedlands, Western Australia, Australia

3. Linear Clinical Research, Nedlands, Western Australia, Australia

4. Pathwest, Nedlands, Western Australia, Australia

Funder

This paper was not funded

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474086.2022.2140138

Reference28 articles.

1. Diffuse Large B-Cell Lymphoma

2. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

3. Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL

4. Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial

5. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: The impact of the addition of rituximab to CHOP chemotherapy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP